Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.76 SEK | -4.70% | -6.22% | +248.96% |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 13-12-31 | |
Director of Finance/CFO | 52 | 19-12-31 | |
Chief Tech/Sci/R&D Officer | 40 | 21-12-31 | |
Carin Linde
CTO | Chief Tech/Sci/R&D Officer | 52 | 18-12-31 |
Andreas Norlin
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-12-31 |
Marie Källström
LAW | General Counsel | 58 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 17-05-31 | |
Niels Mengel
BRD | Director/Board Member | 76 | 99-12-31 |
Director/Board Member | 59 | 16-12-31 | |
Hans Maier
BRD | Director/Board Member | 69 | 16-12-31 |
Lauren Barnes
BRD | Director/Board Member | 50 | 20-05-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,113,431 | 0 | 0 | 74.72 % |
Stock B | 1 | 33,757,746 | 26,055,840 ( 77.18 %) | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+248.96% | 38.2M | |
+23.83% | 48.09B | |
+47.64% | 40.62B | |
-3.02% | 40.43B | |
-6.20% | 28.36B | |
+7.68% | 24.89B | |
-19.31% | 19.01B | |
+29.51% | 12.09B | |
-0.45% | 11.88B | |
+0.07% | 11.8B |
- Stock Market
- Equities
- ACE Stock
- Company Ascelia Pharma AB